Company facts
- Headquarters
- Conshohocken, Pennsylvania
- Most recent report
- 8-K, filed Aug 14, 2026
- Incorporated
- Delaware
- Filings on record
- 1,002+ filings
- On EDGAR
- CIK 1140859
- Fiscal year ends
- September
- Filer status
- Large accelerated filer
Financials 8 of 32
News 8 of 141
- 8-K Leadership change Aug 14, 2026
- 8-K Current report on a material event Aug 12, 2026
- 8-K Significant contract Aug 5, 2026
- 8-K Quarterly results Aug 5, 2026
- 8-K Leadership change Jun 15, 2026
- 8-K Leadership change May 29, 2026
- 8-K Quarterly results May 6, 2026
- 8-K Current report on a material event Mar 23, 2026
Prospectuses and Registrations 8 of 22
- 424B2 Prospectus supplement for an offering Feb 11, 2026
- FWP Free writing prospectus Feb 10, 2026
- 424B5 Prospectus supplement for an offering Feb 10, 2026
- 424B2 Prospectus supplement for an offering May 19, 2025
- FWP Free writing prospectus May 15, 2025
- 424B5 Prospectus supplement for an offering May 15, 2025
- 424B2 Prospectus supplement for an offering Dec 4, 2024
- FWP Free writing prospectus Dec 2, 2024
Proxies 8 of 25
- DEFA14A Extra proxy material Jan 22, 2026
- DEF 14A Proxy statement for a shareholder vote Jan 22, 2026
- DEFA14A Extra proxy material Jan 23, 2025
- DEF 14A Proxy statement for a shareholder vote Jan 23, 2025
- DEFA14A Extra proxy material Jan 29, 2024
- DEF 14A Proxy statement for a shareholder vote Jan 29, 2024
- PRE 14A Preliminary proxy statement Jan 17, 2024
- DEFA14A Extra proxy material Jan 27, 2023
Ownership 8 of 740
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
- 4 Insider reported a trade Sep 2, 2026
- 144 Notice of a proposed sale of restricted stock Sep 1, 2026
- 4 Insider reported a trade Aug 25, 2026
- 144 Notice of a proposed sale of restricted stock Aug 24, 2026
- 144 Notice of a proposed sale of restricted stock Aug 6, 2026
- 4 Insider reported a trade Aug 4, 2026
- 4 Insider reported a trade Aug 4, 2026
Other 8 of 42
- 11-K Employee stock plan report Jun 18, 2026
- SD Conflict minerals disclosure May 29, 2026
- ARS Annual report sent to shareholders Jan 22, 2026
- 11-K Employee stock plan report Jun 17, 2025
- SD Conflict minerals disclosure May 30, 2025
- CERT Exchange certified a listing May 27, 2025
- 8-A12B Registration of a security for exchange listing May 22, 2025
- ARS Annual report sent to shareholders Jan 23, 2025
What to read: Jun 2026 10-Q
SECSift found 2 of 13 sections worth reading, with 6 positive, 7 notable, and 1 negative flags.
Financial Statements (Item 1)
Full financials with major acquisition, debt, and impairment details.Management's Discussion (Item 2)
MD&A with material results, acquisitions, and risk disclosures.Positive- Revenue up 5.1% to $84.8B in Q3 2026, driven by U.S. and international growth.
- GLP-1 sales surged 25.5% to $2.3B in Q3 2026, a key growth driver.
- Gross profit up 24.1% in Q3 2026, lifted by acquisitions and higher LIFO credits.
- Total segment operating income up 17.0% in Q3 2026 from acquisitions and growth.
- U.S. Healthcare gross profit margin rose 63 bps to 3.17% in Q3 2026, aided by OneOncology.
- Cash from operations surged to $1.7B in 9mo 2026, up from $0.7B, improving liquidity.
Notable- $1.1B gain on OneOncology equity remeasurement in 9mo 2026, one-time boost.
- Interest expense net jumped 72% in Q3 2026 due to $4.5B new debt for OneOncology.
- New $2.0B share repurchase program authorized in May 2026; $1.0B bought in 9mo.
- Opioid liability of $4.2B accrued, payable over 13 years; $102M credit from dismissal in Q3.
What changed: Jun 2026 vs. Mar 2026
About 4% of COR's Jun 2026 10-Q is new information. 12 paragraphs were added, 154 changed, and 30 removed. Below are the most important lines SECSift identified.
New
Changed
Everything here comes from Cencora, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Aug 19, 2026, from the 10-Q for Jun 2026.